Medtronic's Visualase Tumor Ablation Tech Beams Into UK Market
Executive Summary
Medtronic's Visualase neurosurgery technology will be available for the first time in the UK to treat brain tumor patients at private London hospital The Harley Street Clinic. The MRI-guided laser therapy treatment has been approved in the US since 2007 but only received the CE mark in April this year.
You may also be interested in...
Market Intel: New Thermal Therapies Blaze Trail In Fast-Growing Cancer Ablation Market
Cancer rates are rising worldwide and as diagnostic techniques continue to improve, new surgical ablation devices are becoming crucial weapons in the growing arsenal of cancer treatment tools. These devices allow doctors to burn away tumors with precision, speed and safety, without the side-effects that patients undergoing radical cancer therapy often experience. This article provides an overview of the cancer ablation market, highlights the key players working on these devices and discusses their potential applications. It also includes critical insights from a leading interventional urologist on the pros and cons of using these various technologies in treating prostate cancer.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.